Minnesota Settles with Eli Lilly, Setting Insulin at $35
ST. PAUL, Minn. (NEWSnet/AP) — Minnesota has reached a settlement with Eli Lilly and Co. in a price gouging lawsuit against the country’s three biggest insulin manufacturers.
People in Minnesota can now buy Lily-produced insulin for only $35 a month for the next five years, Attorney General Keith Ellison announced Wednesday.
The settlement is likely to benefit as many as 500,000 residents whether they have insurance or not, and it covers all Lilly brand-name insulin products, Ellison said at a news conference.
Litigation remains pending against two other manufacturers named in the 2018 lawsuit, Sanofi-Aventis and Novo Nordisk.
New York last year reached a similar settlement with the big three insulin makers, Ellison said. And the attorneys general of California, Illinois, Arizona and Utah, and some local governments, have filed similar lawsuits in the last year, his office said.
Minnesotans can get information on how to access the $35-a-month Lilly insulin at MNinsulin35.org.
Follow NEWSnet on Facebook and X platform to get our headlines in your social feeds.
Copyright 2024 NEWSnet and The Associated Press. All rights reserved.